Features | Partner Sites | Information | LinkXpress
Sign In
FLUKE BIOMEDICAL
SCHILLER AG
Advantech Europe

Noninvasive Prenatal Testing Market Set for Explosive Growth

By HospiMedica International staff writers
Posted on 21 Jan 2014
The global noninvasive prenatal testing (NIPT) market is expected to grow more than ten-fold in the next five years. These are the latest findings of Transparency Market Research (Albany, NY, USA), a global information and research provider.

NIPT, the noninvasive genetic screening test for common chromosomal abnormalities (trisomy 21, trisomy 18, trisomy 13, monosomy X, etc.) can detect the presence of abnormalities in fetuses of pregnant women as early as 9–10 weeks of gestation, with some of the most commonly detected chromosomal aneuploidies include Down syndrome, Edwards syndrome, Patau syndrome, and monosomy X. The market is also evolving rapidly due the advantages it offers over conventional prenatal screening and diagnostic methods such as maternal serum screening, nuchal translucency (NT) scan, amniocentesis, and chorionic villus sampling (CVS). These advantages include safety, accuracy, and no risk of miscarriage.

MaterniT21 PLUS, verifi, Harmony, Panorama, NIFTY, PrenaTest, and BambniTest are currently the commercially available NIPTs, all based on the direct analysis of cell-free fetal DNA in the maternal blood. In 2012, MaterniT21 (a proprietary product of Sequenom) accounted for the largest share (36.6%) of the market in terms of revenue, owing to the fact that it was the first mover in the market place. During the forecast period 2013 to 2019, it is likely to lose some of its share due to increasing market penetration by other, aforementioned NIPTs such as Panorama and verify.

Almost every company in this market is adopting the same business model of marketing their tests via alliances with hospitals, diagnostic laboratories, and physician offices. The increasing penetration by test developers in European, Asia-Pacific, and Middle East countries indicates promising growth in the near future. Sequenom (San Diego, CA, USA), Verinata Health (Redwood City, CA, USA), Ariosa Diagnostics, and Natera (San Carols, CA, USA), are the leading companies engaged in providing noninvasive prenatal tests worldwide.

The global NIPT market was valued at USD 220 million in 2012 and is expected to grow at a compound annual growth rate (CAGR) of 37.6% from 2013 to 2019, to reach an estimated value of USD 3.62 billion by 2019. Geographically, North America was the largest regional market in 2012, with a market share of 64.5% of the total revenue generated globally, followed by Europe.

Related Links:

Transparency Market Research
Sequenom
Verinata Health




Channels

Critical Care

view channel
Image: Scanning electron micrograph of a human neutrophil ingesting MRSA (Photo courtesy [US] National Institutes of Health (NIH)/Wikipedia commons).

Common Biocide Promotes Bacteria in Nasal Passages

Triclosan, an antimicrobial agent found in common household soaps, shampoos, and toothpastes promotes the colonization of Staphylococcus aureus in noses, according to a new study. Researchers at the... Read more

Surgical Techniques

view channel

New Procedure for Laparoscopic Bowel Resection

A novel laparoscopic bowel lifting technique method could help introduce single-incision laparoscopic surgery (SILS) for low anterior resection of rectal cancer. Developed by researchers at Yokohama City University Medical Center (Japan), the laparoscopic bowel-lifting (LBL) technique involves piercing the mesocolon... Read more

Women's Health

view channel

Low-Dose Aspirin Will Not Prevent Pregnancy Loss

A new study reveals that in general, low-dose aspirin is not beneficial for future pregnancy outcomes in women with prior pregnancy loss. Researchers at the University at Buffalo (NY, USA) conducted a placebo-controlled trial that included 1,228 women (aged 18-40 years) who were attempting to become pregnant.... Read more

Hospital News

view channel

ECG Viewer Integration Transforms Cardiology Medical Records

Community Medical Centers (CMC; Fresno, CA, USA), a leading not-for-profit health system comprised of three hospitals and four outpatient centers in central California, has integrated an electrocardiogram (ECG) management system and viewer into their electronic health record (EHR), leading to significant improvements in... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.